Body Composition in Crohn’s Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration

Table 5

Effect of disease behavior, clinical severity, and disease duration on visceral and subcutaneous fat area and visceral to subcutaneous fat ratio (VF/SC).

	Visceral fat area	Subcutaneous fat area	VF/SC ratio
Disease behavior
B1	93.1 ± 59.2	105.8 ± 79.5	1.32 ± 0.8
B2 and B3 ( = 22 and 1)	114.9 ± 79.2	108.4 ± 68.1	1.28 ± 0.7
value	0.31	0.91	0.90
Disease severity
Remission	115.1 ± 54.1	141.04 ± 77.9	0.98 ± 0.4
Mild	97.6 ± 54.9	95.9 ± 58.5	1.37 ± 0.6
Moderate to severe	101.8 ± 99.2	86.2 ± 75.5	1.53 ± 0.9
value	0.79	0.10	0.09
Disease duration (years)
<1 year	106.5 ± 60.8	145.3 ± 88.2	1.09 ± 0.5
1–5 years	93.6 ± 84.6	88.4 ± 62.8	1.36 ± 0.8
>5 years	117.8 ± 55.4	109.4 ± 71.3	1.33 ± 0.6
value	0.61	0.15	0.63

B1: inflammatory; B2: stricturing; B3: penetrating; Remission: CDAI < 150; Mild: CDAI: 150–220; Moderate to severe: CDAI > 220.